
Global Controlled Substances Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Controlled Substances market size will reach US$ million by 2031.
A controlled substance is generally a drug or chemical whose manufacture, possession, or use is regulated by a government, such as illicitly used drugs or prescription medications that are designated by law.
Drugs and other substances that are considered controlled substances under the Controlled Substances Act (CSA) are classified into five schedules. This scheduling is depended on the drug’s acceptable medical use and the drug’s abuse or dependency potential. The CSA scheduling list is annually updated and describes basic or parent chemical. This list is not comprehensive and does not describe salts, isomers, and salts of isomers, esters, ethers, and derivatives.
LPI (LP Information)' newest research report, the “Controlled Substances Industry Forecast” looks at past sales and reviews total world Controlled Substances sales in 2024, providing a comprehensive analysis by region and market sector of projected Controlled Substances sales for 2025 through 2031. With Controlled Substances sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Controlled Substances industry.
This Insight Report provides a comprehensive analysis of the global Controlled Substances landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Controlled Substances portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Controlled Substances market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Controlled Substances and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Controlled Substances.
This report presents a comprehensive overview, market shares, and growth opportunities of Controlled Substances market by product type, application, key players and key regions and countries.
Segmentation by Type:
Opioids
Stimulants
Depressants
Marijuana
Others
Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Pfizer
Siegfried AG
GlaxoSmithKline
Teva Pharmaceuticals
Viatris
Takeda Pharmaceutical
Sun Pharmaceutical
Daiichi Sankyo
Akorn Inc
Tilray
Medical Marijuana, Inc
Consort Medical
Purdue Pharma
Please note: The report will take approximately 2 business days to prepare and deliver.
A controlled substance is generally a drug or chemical whose manufacture, possession, or use is regulated by a government, such as illicitly used drugs or prescription medications that are designated by law.
Drugs and other substances that are considered controlled substances under the Controlled Substances Act (CSA) are classified into five schedules. This scheduling is depended on the drug’s acceptable medical use and the drug’s abuse or dependency potential. The CSA scheduling list is annually updated and describes basic or parent chemical. This list is not comprehensive and does not describe salts, isomers, and salts of isomers, esters, ethers, and derivatives.
LPI (LP Information)' newest research report, the “Controlled Substances Industry Forecast” looks at past sales and reviews total world Controlled Substances sales in 2024, providing a comprehensive analysis by region and market sector of projected Controlled Substances sales for 2025 through 2031. With Controlled Substances sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Controlled Substances industry.
This Insight Report provides a comprehensive analysis of the global Controlled Substances landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Controlled Substances portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Controlled Substances market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Controlled Substances and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Controlled Substances.
This report presents a comprehensive overview, market shares, and growth opportunities of Controlled Substances market by product type, application, key players and key regions and countries.
Segmentation by Type:
Opioids
Stimulants
Depressants
Marijuana
Others
Segmentation by Application:
Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Johnson & Johnson
Pfizer
Siegfried AG
GlaxoSmithKline
Teva Pharmaceuticals
Viatris
Takeda Pharmaceutical
Sun Pharmaceutical
Daiichi Sankyo
Akorn Inc
Tilray
Medical Marijuana, Inc
Consort Medical
Purdue Pharma
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
112 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Controlled Substances Market Size by Player
- 4 Controlled Substances by Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Global Controlled Substances Market Forecast
- 11 Key Players Analysis
- 12 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.